{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:56:37Z","timestamp":1791338197123,"version":"4.3.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Research Program of NIDDK","award":["DK075135-01"],"award-info":[{"award-number":["DK075135-01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.antiviral.2016.08.022","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T06:43:12Z","timestamp":1472625792000},"page":"216-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus"],"prefix":"10.1016","volume":"134","author":[{"given":"T.L.","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.N.","family":"Helfrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hassink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.I.","family":"Shank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2228-6500","authenticated-orcid":false,"given":"K.","family":"George Rosenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Scerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-7568","authenticated-orcid":false,"given":"M.","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Q.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"R.W.","family":"Buckheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.H.","family":"Appella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4749","key":"10.1016\/j.antiviral.2016.08.022_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1126\/science.2421409","article-title":"Potential metal-binding domains in nucleic acid binding proteins","volume":"232","author":"Berg","year":"1986","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.antiviral.2016.08.022_bib2","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.1128\/JVI.67.12.7190-7200.1993","article-title":"Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays","volume":"67","author":"Berkowitz","year":"1993","journal-title":"J.\u00a0Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2016.08.022_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/095632020701800502","article-title":"The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors","volume":"18","author":"Buckheit","year":"2007","journal-title":"Antivir. Chem. Chemother."},{"issue":"1","key":"10.1016\/j.antiviral.2016.08.022_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/AAC.00972-07","article-title":"Comparative evaluation of the inhibitory activities of a series of pyrimidinedione congeners that inhibit human immunodeficiency virus types 1 and 2","volume":"52","author":"Buckheit","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.antiviral.2016.08.022_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.antiviral.2013.09.005","article-title":"Selection and characterization of viruses resistant to the dual acting pyrimidinedione entry and non-nucleoside reverse transcriptase inhibitor IQP-0410","volume":"100","author":"Buckheit","year":"2013","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.antiviral.2016.08.022_bib6","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/JVI.77.2.1469-1480.2003","article-title":"Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA","volume":"77","author":"Buckman","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.022_bib7","unstructured":"Code of federal regulations title 9, pt. 3. Animal and Plant Health Inspection Service; Washington: 2012. Animals and animal products - standards."},{"issue":"2","key":"10.1016\/j.antiviral.2016.08.022_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/nar\/14.2.623","article-title":"Amino acid sequence homology in gag region of reverse transcribing elements and the coat protein gene of cauliflower mosaic virus","volume":"14","author":"Covey","year":"1986","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.antiviral.2016.08.022_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/viro.1998.9374","article-title":"The role of nucleocapsid of HIV-1 in virus assembly","volume":"251","author":"Dawson","year":"1998","journal-title":"Virology"},{"issue":"19","key":"10.1016\/j.antiviral.2016.08.022_bib10","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1128\/JVI.74.19.8980-8988.2000","article-title":"Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer","volume":"74","author":"Guo","year":"2000","journal-title":"J.\u00a0Virol."},{"issue":"9","key":"10.1016\/j.antiviral.2016.08.022_bib11","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1128\/JVI.76.9.4370-4378.2002","article-title":"Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein","volume":"76","author":"Guo","year":"2002","journal-title":"J.\u00a0Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2016.08.022_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jmb.2004.01.054","article-title":"Mechanistic insights into the kinetics of HIV-1 nucleocapsid protein-facilitated tRNA annealing to the primer binding site","volume":"337","author":"Hargittai","year":"2004","journal-title":"J.\u00a0Mol. Biol."},{"issue":"3","key":"10.1016\/j.antiviral.2016.08.022_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.antiviral.2011.10.013","article-title":"Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents","volume":"92","author":"Hartman","year":"2011","journal-title":"Antivir. Res."},{"issue":"9","key":"10.1016\/j.antiviral.2016.08.022_bib14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1021\/jm9708543","article-title":"Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins","volume":"41","author":"Huang","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"issue":"8","key":"10.1016\/j.antiviral.2016.08.022_bib15","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1021\/jm0492195","article-title":"Studies on the mechanism of inactivation of the HIV-1 nucleocapsid protein NCp7 with 2-mercaptobenzamide thioesters","volume":"48","author":"Jenkins","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.022_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12977-015-0218-9","article-title":"Identification and Characterization of a new type of inhibitor against human immunodeficiency virus type-1 nucleocapsid protein","volume":"12","author":"Kim","year":"2015","journal-title":"Retrovirology"},{"issue":"4","key":"10.1016\/j.antiviral.2016.08.022_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/nar\/21.4.831","article-title":"Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle","volume":"21","author":"Lapadat-Tapolsky","year":"1993","journal-title":"Nucleic Acids Res."},{"issue":"21","key":"10.1016\/j.antiviral.2016.08.022_bib18","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1021\/jm960253w","article-title":"Biophysical characterization of zinc ejection from HIV nucleocapsid protein by anti-HIV 2,2'-dithiobis[benzamides] and benzisothiazolones","volume":"39","author":"Loo","year":"1996","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.022_bib19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nchembio.456","article-title":"Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer","volume":"6","author":"Miller Jenkins","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.antiviral.2016.08.022_bib20","first-page":"53","article-title":"Nucleocapsid Protein: a desirable target for future therapies against HIV-1","volume":"389","author":"Mori","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"30","key":"10.1016\/j.antiviral.2016.08.022_bib21","doi-asserted-by":"crossref","first-page":"9600","DOI":"10.1021\/bi9905258","article-title":"Structural investigation on the requirement of CCHH zinc finger type in nucleocapsid protein of human immunodeficiency virus 1","volume":"38","author":"Ramboarina","year":"1999","journal-title":"Biochemistry"},{"issue":"6411","key":"10.1016\/j.antiviral.2016.08.022_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/361473a0","article-title":"Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds","volume":"361","author":"Rice","year":"1993","journal-title":"Nature"},{"issue":"5239","key":"10.1016\/j.antiviral.2016.08.022_bib23","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1126\/science.270.5239.1194","article-title":"Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS","volume":"270","author":"Rice","year":"1995","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.antiviral.2016.08.022_bib24","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1021\/jm960375o","article-title":"Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors","volume":"39","author":"Rice","year":"1996","journal-title":"J.\u00a0Med. Chem."},{"issue":"2","key":"10.1016\/j.antiviral.2016.08.022_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/AAC.41.2.419","article-title":"Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins","volume":"41","author":"Rice","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.antiviral.2016.08.022_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nm0397-341","article-title":"Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein","volume":"3","author":"Rice","year":"1997","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.antiviral.2016.08.022_bib27","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1073\/pnas.91.10.4559","article-title":"Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction","volume":"91","author":"Ryser","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.022_bib28","doi-asserted-by":"crossref","first-page":"9601","DOI":"10.1021\/acs.jmedchem.5b01183","article-title":"Design and synthesis of DiselenoBisBenzamides (DiSeBAs) as nucleocapsid protein 7 (NCp7) inhibitors with anti-HIV activity","volume":"58","author":"Sancineto","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"issue":"2","key":"10.1016\/j.antiviral.2016.08.022_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/088922203762688595","article-title":"In\u00a0vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine model","volume":"19","author":"Schito","year":"2003","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"16","key":"10.1016\/j.antiviral.2016.08.022_bib30","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1021\/bi016045+","article-title":"Affinities of packaging domain loops in HIV-1 RNA for the nucleocapsid protein","volume":"41","author":"Shubsda","year":"2002","journal-title":"Biochemistry"},{"issue":"24","key":"10.1016\/j.antiviral.2016.08.022_bib31","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1016\/j.bmc.2004.09.032","article-title":"Optimization of unique, uncharged thioesters as inhibitors of HIV replication","volume":"12","author":"Srivastava","year":"2004","journal-title":"Bioorg Med. Chem."},{"issue":"5","key":"10.1016\/j.antiviral.2016.08.022_bib32","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1128\/JVI.72.5.4442-4447.1998","article-title":"Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication","volume":"72","author":"Tanchou","year":"1998","journal-title":"J.\u00a0Virol."},{"issue":"9","key":"10.1016\/j.antiviral.2016.08.022_bib33","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1128\/JVI.70.9.6180-6189.1996","article-title":"Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles","volume":"70","author":"Turpin","year":"1996","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2016.08.022_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1021\/jm9802517","article-title":"Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers","volume":"42","author":"Turpin","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"issue":"6","key":"10.1016\/j.antiviral.2016.08.022_bib35","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1128\/JVI.69.6.3878-3884.1995","article-title":"Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing","volume":"69","author":"Zybarth","year":"1995","journal-title":"J.\u00a0Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:28:37Z","timestamp":1601054917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":35,"alternative-id":["S0166354216303175"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.022","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}